NASDAQ · STOCK
Gilead Sciences
$129.81
52W $107.75 – $157.29
66/100
$168.00B
18.1
0.34
Price History (6M)
Executive Summary
5 analysts weighed in with 100% agreement on a bullish lean. Growth Analyst: 4 consecutive earnings beats -- consistent execution. Overall recommendation: BUY.
Bull & Bear Case
Bull Case
- Positive MACD histogram signals bullish momentum.
- Daily volatility (ATR%) above ~3% is treated as elevated risk.
Bear Case
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
- Lower Highs / Lower Lows structure confirms bearish price action.
- Bearish candlestick pattern(s) detected: Three Black Crows.
AI Investment Committee
Committee Consensus
As of July 11, 2026
Overall Committee Score
66/100
Agreement
83%
Analysts
6
Conviction
High
Growth Analyst
bullish
82
/ 100 · Moderate confidence
Strong, accelerating growth with consistent execution
+ 4 consecutive earnings beats -- consistent execution
Technical Analyst
bullish
61
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ MACD histogram positive -- bullish momentum
Macro Analyst
bullish
70
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
bullish
64
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.20 across 34 articles, 14d)
Portfolio Manager
bullish
75
/ 100 · Low confidence
The existing book is healthy enough that position-sizing here is a matter of stock selection, not portfolio constraints
+ Portfolio position concentration is currently healthy
Technical Analysis
RSI (14)
49.2
Neutral
MACD Histogram
1.040
Bullish Momentum
Trend Direction
Sideways
Weekly: Sideways
Market Structure
Lh Ll
Support
$127.64
Resistance
$157.26
Bollinger %B
0.63
Inside Bands
Price vs Moving Averages
EMA 9
$131.10
Below
EMA 21
$129.47
Above
EMA 50
$130.41
Below
EMA 200
$128.55
Above
Fundamental Analysis
Valuation
54
Growth
71
Profitability
100
Financial Health
66
Valuation
P/E Ratio
18.1×
P/B Ratio
6.71×
PEG Ratio
—
Dividend Yield
2.41%
52W High
$157.29
52W Low
$107.75
Quality & Growth
ROE
4221.0%
ROA
1606.0%
Gross Margin
7935.0%
Operating Margin
3488.0%
Revenue Growth YoY
+348.0%
Debt / Equity
1.10
AI Fundamental Assessment
P/E ratio of 18.1 (inexpensive relative to a 15-40x range); Price-to-book of 6.7x; Revenue growth (YoY) of 3.5%; EPS growth (YoY) of 55.5%; Return on equity of 42.2%; Return on assets of 16.1%; Net margin of 31.0%; Gross margin of 79.3%; Current ratio of 1.55 (healthy short-term liquidity); Debt-to-equity of 1.10; Most recent quarter beat estimates by 4.0%; 4 consecutive earnings beats; EPS growth accelerating (-24.7% -> +9.1% QoQ); Analyst estimates falling over recent quarters
Key Risks
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
- Lower Highs / Lower Lows structure confirms bearish price action.
- Bearish candlestick pattern(s) detected: Three Black Crows.
This risk summary is generated from quantitative data signals, not qualitative opinion. All investors should conduct their own due diligence. This is not financial advice.
Get the Full GILD Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Mobile